Phio Pharmaceutical
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHIO and other ETFs, options, and stocks.About PHIO
Phio Pharmaceuticals Corp. is a biotechnology company engaged in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries.
CEOGeert Cauwenbergh, PhD
CEOGeert Cauwenbergh, PhD
Employees12
Employees12
HeadquartersMarlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded2011
Founded2011
Employees12
Employees12
PHIO Key Statistics
Market cap7.09M
Market cap7.09M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume48.74K
Average volume48.74K
High today$6.54
High today$6.54
Low today$6.13
Low today$6.13
Open price$6.20
Open price$6.20
Volume14.40K
Volume14.40K
52 Week high$29.04
52 Week high$29.04
52 Week low$3.90
52 Week low$3.90
PHIO Earnings
-$3.36
-$2.24
-$1.12
-$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 21, After Hours
ActualExpected Mar 21, After Hours